TradeFlare's AI research teams analysed VTRS on 6 market nights between May 11, 2026 and October 9, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| October 9, 2026 | HOLD | $17.44 | $20.06 / $14.82 | not yet | not yet | The layoff news is a potential catalyst, but the mixed technicals and high risk warrant a cautious approach. |
| June 4, 2026 | BUY | $15.56 | — / — | +2.6% | +5.7% | The current market regime and VTRS's risk profile do not support a buy recommendation. |
| June 3, 2026 | BUY | $15.69 | — / — | +1.4% | +7.3% | Positive news sentiment driven by Q1 2026 earnings and FDA acceptance of a new pain therapy. |
| June 2, 2026 | BUY | $15.81 | — / — | +3.2% | +3.1% | Positive news sentiment driven by Q1 2026 earnings and FDA acceptance of a new pain therapy. |
| May 12, 2026 | HOLD | $16.92 | — / — | -5.8% | -8.2% | Continued post-earnings drift (PEAD) following the EPS beat. |
| May 11, 2026 | BUY | $17.17 | — / — | -2.5% | -4.3% | Post-earnings drift (PEAD) signal from EPS beat. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.